SBI Securities
PRME icon

SBI Securities’s Prime Medicine PRME Stock Holding History

SBI Securities’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14K Buy
580
+189
+48% +$628 ﹤0.01% 2536
2026
Q1 		$1.36K Buy
391
+88
+29% +$335 ﹤0.01% 2543
2025
Q4 		$1.05K Sell
303
-697
-70% -$3.1K ﹤0.01% 2627
2025
Q3 		$5.54K Buy
1,000
+273
+38% +$1.11K ﹤0.01% 1996
2025
Q2 		$1.8K Buy
727
+153
+27% +$236 ﹤0.01% 2431
2025
Q1 		$1.14K Sell
574
-631
-52% -$1.61K ﹤0.01% 2525
2024
Q4 		$3.52K Buy
+1,205
New +$4.23K ﹤0.01% 2061

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SBI Securities's PRME Position: Q2 2026 in Review

SBI Securities increased its Prime Medicine (PRME) stake by 48% in Q2 2026, buying an estimated $628 and bringing the position to 580 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2536.

SBI Securities first reported a position in PRME in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.54K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • SBI Securities held 580 shares of Prime Medicine worth $2.14K as of Q2 2026.
  • SBI Securities bought 189 Prime Medicine shares in Q2 2026, an estimated $628.
  • Prime Medicine made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2536 holding.
  • SBI Securities first reported a position in Prime Medicine in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Prime Medicine position peaked at $5.54K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.